Trifecta Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$965K Hold
3,947
0.15% 60
2025
Q4
$817K Sell
3,947
-201
-5% -$39.7K 0.12% 61
2025
Q3
$769K Buy
4,148
+127
+3% +$21.8K 0.12% 62
2025
Q2
$614K Buy
4,021
+1,576
+64% +$242K 0.1% 68
2025
Q1
$405K Sell
2,445
-38
-2% -$5.95K 0.09% 64
2024
Q4
$359K Hold
2,483
0.07% 67
2024
Q3
$402K Sell
2,483
-124
-5% -$19.8K 0.08% 67
2024
Q2
$381K Sell
2,607
-16,624
-86% -$2.47M 0.08% 67
2024
Q1
$3.04M Sell
19,231
-502
-3% -$79.9K 0.74% 40
2023
Q4
$3.09M Sell
19,733
-282
-1% -$43.2K 0.86% 34
2023
Q3
$3.12M Buy
20,015
+167
+0.8% +$27.6K 1% 31
2023
Q2
$3.29M Sell
19,848
-528
-3% -$85.2K 1.06% 25
2023
Q1
$3.16M Buy
20,376
+931
+5% +$150K 1.11% 24
2022
Q4
$3.43M Buy
+19,445
New +$3.36M 1.37% 19

Other funds holding JNJ

Trifecta Capital Advisors's JNJ Position: Q1 2026 in Review

Trifecta Capital Advisors held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 3,947 shares worth $965K. The position accounts for 0.15% of the portfolio, ranked #60.

Trifecta Capital Advisors first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $3.43M in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Trifecta Capital Advisors held 3,947 shares of Johnson & Johnson worth $965K as of Q1 2026.
  • Trifecta Capital Advisors left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up 0.15% of Trifecta Capital Advisors's portfolio in Q1 2026, its #60 holding.
  • Trifecta Capital Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Trifecta Capital Advisors's Johnson & Johnson position peaked at $3.43M in Q4 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Trifecta Capital Advisors's 13F filing for Q1 2026, filed 1 May 2026.